Hip pain predicts arthritis mortality beyond comorbidities

New research from the Osteoarthritis Research Society International that suggests that hip pain increases by one third all-cause mortality in people with osteoarthritis. Also today, COPD patient subset gains no benefit from low-dose theophylline, Barrett’s segment length and low-grade dysplasia are tied to an increased risk of neoplastic progression, and the vestibular/oculomotor component of concussions warrants more attention. 

Listen to the MDedge Daily News podcast for all the details on today’s top news.


 

New research from the Osteoarthritis Research Society International that suggests that hip pain increases by one third all-cause mortality in people with osteoarthritis. Also today, COPD patient subset gains no benefit from low-dose theophylline, Barrett’s segment length and low-grade dysplasia are tied to an increased risk of neoplastic progression, and the vestibular/oculomotor component of concussions warrants more attention. 

Listen to the MDedge Daily News podcast for all the details on today’s top news.


 

New research from the Osteoarthritis Research Society International that suggests that hip pain increases by one third all-cause mortality in people with osteoarthritis. Also today, COPD patient subset gains no benefit from low-dose theophylline, Barrett’s segment length and low-grade dysplasia are tied to an increased risk of neoplastic progression, and the vestibular/oculomotor component of concussions warrants more attention. 

Listen to the MDedge Daily News podcast for all the details on today’s top news.